A key objective is to enable updates to the MS-DRG payment rates that are no longer dependent on gross charges billed by hospitals that are reduced to cost using hospitals' cost report data. Included ...
If additional procedure codes describing CAR T-cell therapies are approved and finalized, CMS will assign them to the most appropriate MS-DRG. Q: CMS created a new MS-DRG for chimeric antigen receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback